Prospects for CBD therapies in basal ganglia disorders.

Summary: Cannabinoids are promising medicines to slow down disease progression in neurodegenerative disorders including Parkinson's disease (PD) and Huntington's disease…

3 years ago

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease.

Summary: We studied whether combinations of botanical extracts enriched in either Δ(9)-tetrahydrocannabinol (Δ(9)-THC) or cannabidiol (CBD), which are the main…

3 years ago

The CBDs as potential antiepileptics.

Summary: Comparative studies of the anticonvulsant properties of the cannabinoids and prototype antiepileptic drugs in numerous animal seizure models demonstrate…

3 years ago

Hypnotic and antiepileptic effects of CBD

Summary: Clinical trials with cannabidiol (CBD) in healthy volunteers, isomniacs, and epileptic patients conducted in the authors' laboratory from 1972…

3 years ago

CBD exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.

Summary: Cannabis sativa has been associated with contradictory effects upon seizure states despite its medicinal use by numerous people with…

3 years ago

CBD: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Summary: To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to…

3 years ago